{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:21:46Z","timestamp":1783117306780,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.7759\/cureus.112012","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:59:22Z","timestamp":1783115962000},"source":"Crossref","is-referenced-by-count":0,"title":["Global Perspective on Fertility-Sparing Surgical Oncology in Gynaecology: A Narrative Literature Review"],"prefix":"10.7759","author":[{"given":"Mario Antonio","family":"Villatoro Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberth Josue","family":"Vera Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Andrea","family":"Gonz\u00e1lez Tangarife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"H\u00edjar Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Ivette","family":"Casas Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Sebasti\u00e1n","family":"Estrella L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-024-03172-z","article-title":"A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia","volume":"41","author":"Goh CS","year":"2024","unstructured":"Goh CS, Loh MJ, Lim WW, et al.. A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia. J Assist Reprod Genet. 2024, 41:2485-94. 10.1007\/s10815-024-03172-z","journal-title":"J Assist Reprod Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2025.101688","article-title":"Evaluation of reproductive and oncological outcomes after fertility-sparing surgery in cervical cancer patients with tumor > 2 cm","volume":"57","author":"Bahrehmand K","year":"2025","unstructured":"Bahrehmand K, Vesztergom D, Budai B, Lengyel D, Luk\u00e1cs E, Nov\u00e1k Z. Evaluation of reproductive and oncological outcomes after fertility-sparing surgery in cervical cancer patients with tumor > 2 cm. Gynecol Oncol Rep. 2025, 57:101688. 10.1016\/j.gore.2025.101688","journal-title":"Gynecol Oncol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.11.1295","article-title":"Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: the FERTIlity Sparing Surgery retrospective multicenter study","volume":"228","author":"Slama J","year":"2023","unstructured":"Slama J, Runnebaum IB, Scambia G, et al.. Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: the FERTIlity Sparing Surgery retrospective multicenter study. Am J Obstet Gynecol. 2023, 228:443.e1-10. 10.1016\/j.ajog.2022.11.1295","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519845974","article-title":"Multicenter research on tumor and pregnancy outcomes in patients with early-stage cervical cancer after fertility-sparing surgery","volume":"47","author":"Wang A","year":"2019","unstructured":"Wang A, Cui G, Jin C, Wang Y, Tian X. Multicenter research on tumor and pregnancy outcomes in patients with early-stage cervical cancer after fertility-sparing surgery. J Int Med Res. 2019, 47:2881-9. 10.1177\/0300060519845974","journal-title":"J Int Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6432-4","article-title":"Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~","volume":"19","author":"Kajiyama H","year":"2019","unstructured":"Kajiyama H, Suzuki S, Yoshikawa N, et al.. Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~. BMC Cancer. 2019, 19:1235. 10.1186\/s12885-019-6432-4","journal-title":"BMC Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1954","article-title":"Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer","volume":"12","author":"Watanabe T","year":"2020","unstructured":"Watanabe T, Soeda S, Nishiyama H, et al.. Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer. Mol Clin Oncol. 2020, 12:44-50. 10.3892\/mco.2019.1954","journal-title":"Mol Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-022-01006-0","article-title":"Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients","volume":"20","author":"Ding Y","year":"2022","unstructured":"Ding Y, Fan Y, Li X, Wang Y, Wang J, Tian L. Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients. Reprod Biol Endocrinol. 2022, 20:134. 10.1186\/s12958-022-01006-0","journal-title":"Reprod Biol Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051008","article-title":"Fertility-sparing surgery in gynecologic cancer: a systematic review","volume":"13","author":"Schuurman T","year":"2021","unstructured":"Schuurman T, Zilver S, Samuels S, et al.. Fertility-sparing surgery in gynecologic cancer: a systematic review. Cancers (Basel). 2021, 13:10.3390\/cancers13051008","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092108","article-title":"Tumor size and oncological outcomes in patients with early cervical cancer treated by fertility preservation surgery: a multicenter retrospective cohort study","volume":"14","author":"Gil-Iba\u00f1ez B","year":"2022","unstructured":"Gil-Iba\u00f1ez B, Gil-Moreno A, Torn\u00e9 A, et al.. Tumor size and oncological outcomes in patients with early cervical cancer treated by fertility preservation surgery: a multicenter retrospective cohort study. Cancers (Basel). 2022, 14:10.3390\/cancers14092108","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000371","article-title":"Fertility-sparing surgery in early-stage cervical cancer patients: oncologic and reproductive outcomes","volume":"25","author":"Ditto A","year":"2015","unstructured":"Ditto A, Martinelli F, Bogani G, et al.. Fertility-sparing surgery in early-stage cervical cancer patients: oncologic and reproductive outcomes. Int J Gynecol Cancer. 2015, 25:493-7. 10.1097\/IGC.0000000000000371","journal-title":"Int J Gynecol Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002076","article-title":"Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer \u22652 cm","volume":"31","author":"Rend\u00f3n GJ","year":"2021","unstructured":"Rend\u00f3n GJ, Lopez Blanco A, Aragona A, et al.. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer \u22652 cm. Int J Gynecol Cancer. 2021, 31:462-7. 10.1136\/ijgc-2020-002076","journal-title":"Int J Gynecol Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.10.010","article-title":"Fertility-preserving surgery for advanced stage ovarian germ cell tumors","volume":"147","author":"Nasioudis D","year":"2017","unstructured":"Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K. Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecol Oncol. 2017, 147:493-6. 10.1016\/j.ygyno.2017.10.010","journal-title":"Gynecol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000647","article-title":"Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy","volume":"30","author":"Tesfai FM","year":"2020","unstructured":"Tesfai FM, Kroep JR, Gaarenstroom K, et al.. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2020, 30:115-21. 10.1136\/ijgc-2019-000647","journal-title":"Int J Gynecol Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2024-005418","article-title":"Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis","volume":"34","author":"Ditto A","year":"2024","unstructured":"Ditto A, Martinelli F, Dri M, et al.. Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis. Int J Gynecol Cancer. 2024, 34:1529-35. 10.1136\/ijgc-2024-005418","journal-title":"Int J Gynecol Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2023.101226","article-title":"Conservative treatment of cervical cancer: a single center experience over a two-decade period","volume":"48","author":"Rey Valzacchi GM","year":"2023","unstructured":"Rey Valzacchi GM, Odetto D, Saadi JM, et al.. Conservative treatment of cervical cancer: a single center experience over a two-decade period. Gynecol Oncol Rep. 2023, 48:101226. 10.1016\/j.gore.2023.101226","journal-title":"Gynecol Oncol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1456376","article-title":"Adoption strategies of fertility-sparing surgery for early-stage cervical cancer patients based on clinicopathological characteristics: a large retrospective cohort study","volume":"11","author":"Ning Y","year":"2024","unstructured":"Ning Y, Gao X, Kong Y, et al.. Adoption strategies of fertility-sparing surgery for early-stage cervical cancer patients based on clinicopathological characteristics: a large retrospective cohort study. Front Surg. 2024, 11:1456376. 10.3389\/fsurg.2024.1456376","journal-title":"Front Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071081","article-title":"Fertility-sparing surgery versus radical hysterectomy in early cervical cancer: a propensity score matching analysis and noninferiority study","volume":"12","author":"Llueca A","year":"2022","unstructured":"Llueca A, Iba\u00f1ez MV, Torne A, et al.. Fertility-sparing surgery versus radical hysterectomy in early cervical cancer: a propensity score matching analysis and noninferiority study. J Pers Med. 2022, 12:10.3390\/jpm12071081","journal-title":"J Pers Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004669","article-title":"Fertility sparing therapy in women with lymph node negative cervical cancer> 2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy","volume":"33","author":"Plaikner A","year":"2023","unstructured":"Plaikner A, Siegler K, Hertel H, et al.. Fertility sparing therapy in women with lymph node negative cervical cancer> 2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy. Int J Gynecol Cancer. 2023, 33:1542-7. 10.1136\/ijgc-2023-004669","journal-title":"Int J Gynecol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000381771","article-title":"An analysis of prognostic factors in patients with ovarian malignant germ cell tumors who are treated with fertility-preserving surgery","volume":"81","author":"Yang ZJ","year":"2016","unstructured":"Yang ZJ, Liu ZC, Wei RJ, Li L. An analysis of prognostic factors in patients with ovarian malignant germ cell tumors who are treated with fertility-preserving surgery. Gynecol Obstet Invest. 2016, 81:1-9. 10.1159\/000381771","journal-title":"Gynecol Obstet Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17197103","article-title":"Outcome and subsequent pregnancy after fertility-sparing surgery of early-stage cervical cancers","volume":"17","author":"Lee CY","year":"2020","unstructured":"Lee CY, Chen YL, Chiang YC, et al.. Outcome and subsequent pregnancy after fertility-sparing surgery of early-stage cervical cancers. Int J Environ Res Public Health. 2020, 17:10.3390\/ijerph17197103","journal-title":"Int J Environ Res Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurox.2019.100071","article-title":"Fertility-sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting","volume":"4","author":"Kajiyama H","year":"2019","unstructured":"Kajiyama H, Yoshihara M, Tamauchi S, Yoshikawa N, Suzuki S, Kikkawa F. Fertility-sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting. Eur J Obstet Gynecol Reprod Biol X. 2019, 4:100071. 10.1016\/j.eurox.2019.100071","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01316-w","article-title":"The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary","volume":"16","author":"Gama Q","year":"2023","unstructured":"Gama Q, Luo S, Wu P, et al.. The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary. J Ovarian Res. 2023, 16:235. 10.1186\/s13048-023-01316-w","journal-title":"J Ovarian Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e42","article-title":"Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma","volume":"35","author":"Li X","year":"2024","unstructured":"Li X, Wang Y, Wang J, Zhou J, Wang J. Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. J Gynecol Oncol. 2024, 35:e42. 10.3802\/jgo.2024.35.e42","journal-title":"J Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506708-global-perspective-on-fertility-sparing-surgical-oncology-in-gynaecology-a-narrative-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:59:23Z","timestamp":1783115963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506708-global-perspective-on-fertility-sparing-surgical-oncology-in-gynaecology-a-narrative-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.112012","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}